Figure 5.
Figure 5. IFN-γ production by NK cells from NOD/SCID mice. (A) FACS sorter-purified CD56+ NK cells from BM of growth factor (GF)–treated NOD/SCID mice (I: n = 3), NK cells generated in vitro within 4 weeks from BM of GF-treated (II: n = 3) and untreated control (III: n = 5) NOD/SCID mice, and purified NK cells isolated from human PB mononuclear cells (IV: n = 2) were stimulated with medium containing IL-2 (□) or IL-12 and IL-18 (▪) for 36 hours. Synthesis of IFN-γ was measured by intracellular FACS analysis, and the mean ± SEM percentages of IFN-γ+ NK cells are shown. (B) Representative FACS pictures of IFN-γ–producing NK cells generated in cultures II, III, and IV are shown. Numbers represent the percentages of total cells in culture.

IFN-γ production by NK cells from NOD/SCID mice. (A) FACS sorter-purified CD56+ NK cells from BM of growth factor (GF)–treated NOD/SCID mice (I: n = 3), NK cells generated in vitro within 4 weeks from BM of GF-treated (II: n = 3) and untreated control (III: n = 5) NOD/SCID mice, and purified NK cells isolated from human PB mononuclear cells (IV: n = 2) were stimulated with medium containing IL-2 (□) or IL-12 and IL-18 (▪) for 36 hours. Synthesis of IFN-γ was measured by intracellular FACS analysis, and the mean ± SEM percentages of IFN-γ+ NK cells are shown. (B) Representative FACS pictures of IFN-γ–producing NK cells generated in cultures II, III, and IV are shown. Numbers represent the percentages of total cells in culture.

Close Modal

or Create an Account

Close Modal
Close Modal